Breaking News

WuXi Biologics to Build New Biologics Center

48,000L mfg. facility will be one of the largest in northern China

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi Biologics has begun construction on a Biologics Manufacturing Center of excellence in the city of Shijiazhuang, a one hour train ride from Beijing.   The new Biologics Center will be equipped with 48,000L bioreactor capacity and will be built to meet cGMP standards of the U.S., EU and China. It will mark the eighth drug substance manufacturing facility of WuXi Biologics, which says it plans to have more than 220,000L total manufacturing capacity by 2021.   “We are pleased to break...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters